| (Values in U.S. Thousands) | Apr, 2018 | Apr, 2017 | Apr, 2016 | Apr, 2015 | Oct, 2017 |
| Sales | 416,410 | 380,320 | 416,220 | 295,470 | 9,860 |
| Sales Growth | +9.49% | -8.63% | +40.87% | +2,896.65% | unch |
| Net Income | 21,550 | 29,240 | 22,500 | 7,910 | 4,340 |
| Net Income Growth | -26.30% | +29.96% | +184.45% | +82.26% | unch |
Consort Med Plc ADR (CSRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Consort Medical Plc engages in the design, development, manufacture and sale of medical drug delivery devices. It operates through the Bespak and Aesica segments. Bespak segment develops and produces drug delivery devices which serves pharmaceutical companies with inhaler and auto-injector technologies. Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. Consort Medical Plc is headquartered in Hemel Hempstead, United Kingdom.
Fiscal Year End Date: 04/30